What You Should Know:
Insilico Medicine (“Insilico”), a generative artificial intelligence (AI)-driven clinical-stage biotechnology company, today announced that the company has initiated the first-in-human study for ISM5411, a potentially first-in-class PHD inhibitor for the treatment…
Continue Reading
What You Should Know: Yseop, a world-leading Generative AI company for life sciences, today announces the closing of a strategic investment round, with new investor Novartis (dRx Capital), joining existing investors Eli Lilly, NextStage…
Continue Reading
Wolters Kluwer Health offers a service called UpToDate, consulted by doctors around the world to help their clinical decision making. In this video, chief medical officer Peter Bonis explains how they are working to…
Continue Reading
Lance Hill, CEO of Within3
The cancer market for the pharma industry accounts for about a third of their product pipeline. With oncology drug sales set to top $390 billion by 2027, life science companies…
Continue Reading
Absci, a startup focused on developing generative AI antibody discovery technology, announced a potential $247 million partnership with pharma giant AstraZeneca to focus on expediting the discovery of novel cancer treatments with the help…
Continue Reading
From the discovery of penicillin in the early 20th century to the development of today’s cutting-edge biologics, the pharmaceutical industry has always been at the forefront of science and innovation.
Presently, this industry is grappling…
Collaborating for biologic breakthroughs, IBM and Boehringer Ingelheim merge genAI with foundation models. IBM’s cutting-edge AI expedites antibody discovery, targeting diseases like cancer, autoimmune disorders, and infections. Boehringer’s validation of refined antibodies affirms in-silico…
Continue Reading
Pharmaceutical giant AstraZeneca announced the launch of Evinova, a health technology business focused on bringing digital health solutions already in use globally by the pharma company to clinical research organizations (CROs), trial sponsors and…
Continue Reading
Partnerships between pharma and healthtech have great potential—but delivering on those partnerships requires overcoming challenges. Expectation and communications can sometimes make effective collaboration difficult. Listen as Ameya Phadke, patient non-pharma solutions leader at Chiesi…
Continue Reading
The INVEST Digital Health conference, a collaboration between MedCity News and the Health Wildcatters accelerator, is coming up this Thursday, October 26. Held at Pegasus Park in Dallas, the conference spotlights a wide range…
Continue Reading
